Paradise Valley, AZ, United States of America

Ramesh K Ramanathan

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ramesh K Ramanathan: Innovator in Cancer Treatment

Introduction

Ramesh K Ramanathan is a notable inventor based in Paradise Valley, AZ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent.

Latest Patents

Ramesh holds a patent for "Methods and materials for assessing and treating cancer." This patent outlines methods and materials involved in assessing cancer, particularly breast cancer. It provides insights into determining whether a cancer patient with ER−/PgR−/HER2− cancer cells is likely to have a favorable or unfavorable outcome. Additionally, it discusses the likelihood of responding to cancer treatments that include a PD-1 inhibitor and/or PD-L1 inhibitor in combination with a JAK2 inhibitor. The patent also details methods for treating mammals with ER−/PgR−/HER2− cancer by administering these inhibitors.

Career Highlights

Ramesh is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in cancer treatment. His work is pivotal in developing new therapeutic strategies for patients suffering from aggressive forms of cancer.

Collaborations

Ramesh collaborates with esteemed colleagues, including Mitesh J Borad and Michael T Barrett, who contribute to his research efforts and enhance the impact of his work in the medical field.

Conclusion

Ramesh K Ramanathan's innovative approach to cancer treatment exemplifies the vital role of inventors in advancing medical science. His contributions are paving the way for improved outcomes for cancer patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…